Esperion Therapeutics, Inc. · NASDAQ:ESPR

BB Biotech AG's stake in Esperion Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)

Event Mar 4, 2025 · Filed Mar 10, 2025

BB Biotech AG's stake in Esperion Therapeutics, Inc. fell to 4.90%, 9,694,064 shares, as a passive investor on Mar 4, 2025. Filed Mar 10, 2025 (Schedule 13G/A).

Stake
4.90%
Shares
9,694,064
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
BB Biotech AG4.90%9,694,064
Biotech Target N.V.4.90%9,694,064

Source

View original at SEC

Related